The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwCLL 2017 | Why aren’t cytogenetic analyses being implemented into clinical studies of CLL?
Panagiotis Baliakas, MD, PhD, from Uppsala University, Uppsala, Sweden, explains the reasons why cytogenetic analyses are seldom performed in clinical studies and diagnoses of chronic lymphocytic leukemia (CLL). He also notes a parallel study being conducted in the European research organization, ERIC, that is currently evaluating methodologies similar to cytogenetic analyses that may be able to replace them. This video was recorded at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2017 in New York, NY.
